Bruce & Co
Latest statistics and disclosures from Bruce & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UHAL.B, ABBV, NextEra Energy, ALL, Merck & Co, and represent 41.55% of Bruce & Co's stock portfolio.
- Added to shares of these 5 stocks: AER (+$7.6M), ADM, BG, DAR, FATE.
- Started 1 new stock position in AER.
- Reduced shares in these 7 stocks: SIRI (-$12M), ABBV, UHAL.B, DUK, Merck & Co, Valeant Pharmaceuticals Int, CMS.
- Bruce & Co was a net seller of stock by $-5.7M.
- Bruce & Co has $344M in assets under management (AUM), dropping by 13.04%.
- Central Index Key (CIK): 0001358331
Tip: Access up to 7 years of quarterly data
Positions held by Bruce & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bruce & Co
Bruce & Co holds 41 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Uhaul B Common (UHAL.B) | 10.6 | $37M | -6% | 508k | 72.00 |
|
| Abbvie Common (ABBV) | 8.4 | $29M | -9% | 147k | 197.48 |
|
| Nextera Energy Common | 8.2 | $28M | 333k | 84.53 |
|
|
| Allstate Common (ALL) | 7.2 | $25M | 131k | 189.65 |
|
|
| Merck Common | 7.1 | $24M | -4% | 215k | 113.56 |
|
| Duke Energy Common (DUK) | 6.6 | $23M | -4% | 196k | 115.30 |
|
| CMS Energy Common (CMS) | 6.4 | $22M | -3% | 310k | 70.63 |
|
| At & T Common (T) | 6.3 | $22M | 984k | 22.00 |
|
|
| Abbott Common (ABT) | 5.1 | $17M | 152k | 114.01 |
|
|
| XEL Energy Common (XEL) | 3.7 | $13M | 196k | 65.30 |
|
|
| Insteel Common (IIIN) | 3.1 | $11M | 343k | 31.09 |
|
|
| Apple Common (AAPL) | 2.7 | $9.3M | 40k | 233.00 |
|
|
| Pfizer Common (PFE) | 2.3 | $8.0M | 276k | 28.94 |
|
|
| Avista Common (AVA) | 2.3 | $7.8M | 202k | 38.75 |
|
|
| Bunge Common (BG) | 2.3 | $7.7M | +60% | 80k | 96.64 |
|
| AerCap Holdings Common (AER) | 2.2 | $7.6M | NEW | 80k | 94.72 |
|
| Darling Ingredients Common (DAR) | 2.2 | $7.5M | +34% | 201k | 37.16 |
|
| Archer Daniels Common (ADM) | 1.7 | $6.0M | +100% | 100k | 59.74 |
|
| Uhaul Common (UHAL) | 1.7 | $5.8M | 75k | 77.48 |
|
|
| Newmont Common (NEM) | 1.6 | $5.3M | 100k | 53.45 |
|
|
| Bausch Health Common | 1.1 | $3.7M | -18% | 450k | 8.16 |
|
| Rli Common (RLI) | 1.0 | $3.5M | 22k | 154.98 |
|
|
| Vicor Common (VICR) | 0.9 | $2.9M | 70k | 42.10 |
|
|
| Supernus Common (SUPN) | 0.7 | $2.6M | 82k | 31.18 |
|
|
| IGM Bioscience Common (IGMS) | 0.5 | $1.7M | 100k | 16.54 |
|
|
| Personalis Common (PSNL) | 0.5 | $1.6M | 300k | 5.38 |
|
|
| Edap Common (EDAP) | 0.4 | $1.4M | 554k | 2.55 |
|
|
| XM Sirius Common (SIRI) | 0.4 | $1.3M | -90% | 56k | 23.65 |
|
| Ashland Common | 0.4 | $1.3M | 15k | 86.97 |
|
|
| Accelerate Diagnostic Cv 5.0% (Principal) | 0.4 | $1.3M | 3.2M | 0.40 |
|
|
| Lava Theraputics Common (LVTX) | 0.4 | $1.3M | 772k | 1.66 |
|
|
| Fate Theraputics Common (FATE) | 0.4 | $1.2M | +16% | 350k | 3.50 |
|
| Mannkind Common (MNKD) | 0.4 | $1.2M | 195k | 6.26 |
|
|
| Kodiak Sciences Common (KOD) | 0.3 | $1.1M | 423k | 2.61 |
|
|
| Viatris Common (VTRS) | 0.2 | $683k | 59k | 11.61 |
|
|
| Organon Common (OGN) | 0.2 | $600k | 31k | 19.13 |
|
|
| Caribou Biosciences Common (CRBU) | 0.2 | $588k | 300k | 1.96 |
|
|
| WEC Energy Common (WEC) | 0.1 | $434k | 4.5k | 96.18 |
|
|
| 908 Devices Common (MASS) | 0.1 | $237k | 68k | 3.47 |
|
|
| Acorda Theraputics Cv 6.0% (Principal) | 0.1 | $200k | 5.0M | 0.04 |
|
|
| Warner Bros. Discovery Common (WBD) | 0.0 | $98k | 12k | 8.25 |
|
Past Filings by Bruce & Co
SEC 13F filings are viewable for Bruce & Co going back to 2010
- Bruce & Co 2024 Q3 filed Nov. 14, 2024
- Bruce & Co 2024 Q2 filed Aug. 9, 2024
- Bruce & Co 2024 Q1 filed May 13, 2024
- Bruce & Co 2023 Q4 filed Feb. 12, 2024
- Bruce & Co 2023 Q3 filed Nov. 13, 2023
- Bruce & Co 2023 Q2 filed Aug. 8, 2023
- Bruce & Co 2023 Q1 filed May 12, 2023
- Bruce & Co 2022 Q4 filed Feb. 15, 2023
- Bruce & Co 2022 Q3 filed Nov. 15, 2022
- Bruce & Co 2022 Q2 filed Aug. 9, 2022
- Bruce & Co 2022 Q1 filed May 11, 2022
- Bruce & Co 2021 Q4 filed Feb. 16, 2022
- Bruce & Co 2021 Q3 filed Nov. 12, 2021
- Bruce & Co 2021 Q2 filed Aug. 16, 2021
- Bruce & Co 2021 Q1 filed May 17, 2021
- Bruce & Co 2020 Q4 filed Feb. 16, 2021